PCI Acquires Biotec, Expands Global Clinical Services
Packaging Coordinators, Inc. (PCI) announced its acquisition of clinical services provider Biotec Services. PCI says the acquisition expands its presence in the U.K./EU territories to support global drug clinical trials and clinical trial suppliers.
Biotec Services is also a temperature controlled pharmaceutical services company that offers storage capacity, packaging, and shipment of Cold Chain products. Biotec recently announced the expansion of its facilities, including the construction of a new facility to store Advanced Therapeutic Medicinal Products (ATMP), such as gene therapies, stem cells, and tissue-engineered products.
With the addition of packaging, storage, and distribution capacity as well as consultative services, PCI expects the acquisition to help enlarge its presence in outsourcing solutions for drug development and marketing. In August, the company also announced its acquisition of Penn Pharma and the subsequent upgrading of its clinical trial services to add pharmaceutical development and manufacturing capabilities.
Bill Mitchell, CEO and President of PCI, said that the addition of Biotec and its team complements its business direction. “Adding Biotec, as well as the drug development and manufacturing expertise of Penn Pharma, truly positions PCI to provide that substantial added value to our clients. I am very excited about the depth of the solutions we can provide our clients to address their daily challenges in bringing new products to successful commercialization.”
Fiona Withey, CEO of Biotec Services, said, “In a recent client survey, our clients told us that we should continue to do what we are doing, but should aim to develop the scope and global presence of our offering. Joining the PCI family allows us to deliver a truly global service to our clients across a wider range of services, while staying true to our core values of expertise, customer service, efficiency, and flexibility.”
No financial terms of the agreement were disclosed by either company.